Skip to main content
. Author manuscript; available in PMC: 2021 Aug 10.
Published in final edited form as: J Control Release. 2020 Jun 10;324:679–694. doi: 10.1016/j.jconrel.2020.06.006

Figure 7.

Figure 7.

DPSC-EXO were used as cargo to validate the EXO-MS platform in vitro. Biologic activity of EXO-MS eluent (0.1 mg/mL EXO-MS in odontogenic media) demonstrated by mineralization (A, B) and odontogenic differentiation (C) of hDPSCs after two weeks of exposure, due to the controlled release of DPSC-EXO. Blank EXO-MS showed negligible therapeutic effect, while DPSC-EXO loaded EXO-MS showed significant increases in both mineralization and odontogenic gene expression.